Losing The War? Novo's Prandin Patent Ruled Invalid After Generics Cleverly Blocked At FDA

Use of repaglinide in combination with metformin is obvious, judge rules in finding the method of use patent invalid; the ruling may clear the way for generic competition, but Caraco still faces manufacturing hurdle.